Can dose proximal to the PTV influence the risk of distant metastases in SBRT lung cancer patients?

被引：0
|
作者：
Diamant, A. [1 ]
Chatterjee, A. [1 ]
El Naqa, I. [2 ]
Bahig, H. [3 ]
Filion, E. [3 ]
Robinson, C. [4 ]
Faria, S. [5 ]
Al-Halabi, H. [5 ]
Adil, K. [5 ]
Seuntjens, J. [1 ]
机构：
[1] McGill Univ, Med Phys Unit, Montreal, PQ, Canada
[2] Michigan Univ, Dept Radiat Oncol, Ann Arbor, MI USA
[3] Ctr Hosp Univ Montreal, Dept Radiat Oncol, Montreal, PQ, Canada
[4] Univ Washington St Louis, Dept Radiat Oncol, St Louis, MO USA
[5] McGill Univ, Ctr Hlth, Dept Radiat Oncol, Montreal, PQ, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2018年 / 127卷
关键词：
D O I：
10.1016/S0167-8140(18)31065-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-0755
引用
收藏
页码：S389 / S389
页数：1
相关论文
共 50 条
  • [1] Can dose outside the PTV influence the risk of distant metastases in stage I lung cancer patients treated with stereotactic body radiotherapy (SBRT)?
    Diamant, Andre
    Chatterjee, Avishek
    Faria, Sergio
    El Naqa, Issam
    Bahig, Houda
    Filion, Edith
    Robinson, Cliff
    Al-Halabi, Hani
    Seuntjens, Jan
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 128 (03) : 513 - 519
  • [2] Can Dose Metrics Predict Distant Metastases in SBRT Nonesmall Cell Lung Cancer Patients?
    Diamant, A. A.
    El Naqa, I.
    Faria, S.
    Seuntjens, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E452 - E452
  • [3] Impact of the dose outside the PTV on distant recurrence in coplanar and non-coplanar lung SBRT
    Heng, V. J.
    Diamant, A.
    Chatterjee, A.
    Faria, S.
    Bahig, H.
    Filion, E.
    Doucet, R.
    El Naqa, I.
    Seuntjens, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S531 - S531
  • [4] Can PTV Density Be Overridden for SBRT Lung Planning?
    Fu
    Perera, H.
    Rudoler, S.
    Yu, Y.
    [J]. MEDICAL PHYSICS, 2013, 40 (06)
  • [5] Evaluation of PTV Dose Margins for Lung SBRT On Cyberknife Treatment
    Fan, J.
    Wang, L.
    Jin, L.
    Xu, Q.
    Chen, X.
    Li, J.
    Price, R.
    Ma, C.
    [J]. MEDICAL PHYSICS, 2013, 40 (06)
  • [6] EFFECTS OF SETUP CORRECTIONS ON THE DOSE DISTRIBUTION OF SBRT OF LUNG CANCER: DOSE INVARIANCE INVALID BUT THE PTV CONCEPT HOLDS
    Holt, A.
    van Vliet-Vroegindeweij, C.
    Sonke, J. J.
    Damen, E. M. F.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S124 - S125
  • [7] Does the Omission of a CTV for NSCLC SBRT Patients Result in Increased Risk of Distant Metastases?
    Diamant, A.
    El Naqa, I.
    Faria, S.
    Seuntjens, J.
    [J]. MEDICAL PHYSICS, 2017, 44 (06) : 3107 - 3107
  • [8] Can Spine SBRT Patients Shrug Off Their PTV Coverage?
    Sarkar, V.
    Huang, L.
    Lloyd, S.
    Paxton, A.
    Salter, B. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E518 - E518
  • [9] Impact of choice of dose calculation algorithm on PTV and OAR doses in lung SBRT
    Chopra, Kashmiri L.
    Harkenrider, Matthew M.
    Emami, B.
    Melian, Edward
    Avadhani, Jaiteerth S.
    Kehwar, T. S.
    Rai, D. V.
    Sethi, Anil
    [J]. JOURNAL OF RADIATION ONCOLOGY, 2019, 8 (03) : 291 - 304
  • [10] Influence of "radioresistant" histologies on SBRT outcome for lung metastases
    Franceschini, D.
    Cozzi, L.
    De Rose, F.
    Navarria, P.
    D'Agostino, G. R.
    Tomatis, S.
    Franzese, C.
    Comito, T.
    Lobefalo, F.
    Mancosu, P.
    Scorsetti, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S351 - S351
12345